Video Experimental Relacionado
Updated: Feb 15, 2026
08:14
A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
Published on: August 28, 2018
8.7K
El panorama terapéutico en evolución de la inhibición de PCSK9
Brett S Mansfield1, Yakubu Bene-Alhasan2, Christie M Ballantyne3
1Carbohydrate & Lipid Metabolism Research Unit, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Atherosclerosis
|February 13, 2026
Resumen
Los inhibidores de la proproteína convertasa subtilisina/kexina tipo 9 (PCSK9) reducen el colesterol LDL, disminuyendo el riesgo de enfermedad cardiovascular. Las terapias aprobadas y los tratamientos novedosos ofrecen nuevas opciones para el manejo de la hipercolesterolemia.
Área de la Ciencia:
- Medicina Cardiovascular
- Genética
- Farmacología
Sus antecedentes:
- La enfermedad cardiovascular es una causa principal de muerte a nivel mundial.
- El colesterol de lipoproteínas de baja densidad (LDL) es un factor de riesgo modificable importante.
- La proproteína convertasa subtilisina/kexina tipo 9 (PCSK9) regula la expresión del receptor de LDL, influyendo en los niveles de colesterol LDL.
Objetivo del estudio:
- Revisar la evidencia de los inhibidores de PCSK9 aprobados.
- Discutir las novedosas terapias dirigidas a PCSK9 en desarrollo.
- Explorar las indicaciones en expansión para la inhibición de PCSK9.
Principales métodos:
- Revisión de la literatura científica sobre inhibidores de PCSK9.
- Resumen de datos de ensayos clínicos para terapias aprobadas.
- Discusión de estrategias terapéuticas emergentes, incluida la edición genética.
Principales resultados:
- Las variantes de PCSK9 con pérdida de función confirman su papel como objetivo terapéutico.
- Los inhibidores de PCSK9 (anticuerpos monoclonales, ARNi, agentes orales) reducen eficazmente el colesterol LDL.
- La validación genética apoya a PCSK9 como objetivo para la hipercolesterolemia.
Conclusiones:
- La inhibición de PCSK9 es una estrategia validada para el manejo de la hipercolesterolemia.
- Existe una gama de terapias dirigidas a PCSK9 disponibles y en desarrollo.
- La inhibición de PCSK9 muestra promesa para una prevención más amplia de enfermedades cardiovasculares.
Videos de Conceptos Relacionados
00:46Feedback Inhibition
57.4K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.4K
01:30Enzyme Inhibition
92.9K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.9K
01:13Therapeutic Index
7.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.0K
02:34Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
01:30Therapeutic Communication
8.8K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.8K
01:26Cholinergic Antagonists: Therapeutic Uses
1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K